April 29th 2025
IQVIA’s Doug Long offers a lay of the land, including trends and developing issues that are shaping the current market.
April 28th 2025
The company’s branded form of nadofaragene firadenovec-vncg will also be produced at a hub in Parsippany, NJ.
April 24th 2025
The deal for the San Diego hub provides the CDMO with its first-ever North American manufacturing location for prefilled syringes and cartridges.
April 15th 2025
One expert's take on reshoring pharma manufacturing services in the US amid likely tariffs to drugs looming.
A panel discussion uncovers ways to deliver personalized therapy ops in a timely fashion.
Biopharma is an active user of consulting services, whose revenue is up 10.5%
Technology projects, M&A and reimbursement questions drive growth
Battle fronts in the illicit online pharmacy war
The annual Operation Pangea nets a next crop of crooks; consumer groups raise awareness
A conversation with Terry Hisey, Deloitte
Projected 2017 medical cost growth will be 'flat,' says PwC
A repeat of the +6.5% cost trend indicates that medical costs are still rising above inflation
HDMA is now the Healthcare Distribution Alliance
Internationalization of drug wholesaling is a factor in the name change
Global oncology drug market was $107 billion in 2015, up 11.5%
Branded products are 92% US market in dollar value, says IMS Institute
Patient copays: the growth mechanism of the pharma industry?
Bloomberg BusinessWeek rakes over charitable copay programs
US biopharma industry: 854,000 jobs, $1.2 trillion in total economic output
PhRMA-sponsored study outlines the economic effects of US-based operations
Cigna negotiates first performance-based contracts for PCSK9 drugs
Deals with Amgen and Sanofi/Regeneron enhance new pricing policies for specialty drugs
2016 EMD Serono Specialty Digest: health plans’ ongoing cost struggle
Managed care organizations are adjusting rapidly to onslaught of specialty products
Specialty pharmacy dynamics
The SP channel continues to grow, with manufacturers looking for more control over access
A Conversation with Mark Merritt, Pharmaceutical Care Management Association
IMS Health and Quintiles to merge
Both clinical research and commercial analytics markets to be served by combination
Another tough week for pharma on drug pricing policy
More healthcare stakeholders line up against the industry
Abbott bets on medical devices with $25-billion acquisition of St. Jude Medical
Better access to hospital systems is a goal; pharmaceutical business is fading
IMS 2015 Use of Medicines report: US sales reach $424.8 billion
Double-digit growth (12.2%) for the second year running
Pfizer cancels merger with Allergan; hey, what about Inflectra biosimilar?
US tax rules scuttle merger, while the US' second biosimilar wins FDA approval
Biosimilars represent a $56-110-billion savings potential in 2016-2020, says IMS Institute
Experience--mostly in Europe--indicates a heavy educational burden for patients and physicians
Walgreens and OptumRx partnership: more consolidation in retail pharmacy
Partnership combines mail-order PBM with brick-and-mortar drugstores
Express Scripts 2015 Drug Trend: not so bad in drug price escalation
Annual report highlights company's cost-control measures
Spectra Selling Solutions: a new player in contract sales organizations
New subsidiary of The Medical Affairs Co. hopes to fill gaps in CSO offerings
Use data analytics to monitor 340B discount drug pricing
Discerning how and where products are discounted is an expensive headache for manufacturers
A Conversation with Matt Wallach, Veeva Systems
Bringing value to healthcare: practical steps for getting to a market-based model
A new, market-driven model of drug development and commercialization is appearing*
A case study in differing approaches to reimbursement approval in Europe and the US
Looking at 'cost' and 'value' under different evaluation processes
With private-equity help, Inmark moves deeper into pharma cold chain packaging
Quad-C investment will enable future acquisitions
McKesson commits $3.1 billion to acquire Canadian pharmacies and US oncology services
Canada's Rexall chain, plus Biologics, Inc, and Vantage Oncology
Donald Trump is no friend of the pharma industry
New healthcare proposals re-open talk of drug importation
IFPW initiates its charitable efforts in Africa with GAVI
Global drug-wholesaler group plans future educational and developmental work
Managing logistics partnerships in uncertain times
Outsourced services can provide significant financial and risk-avoidance benefits